Citadel Advisors - ARGOS THERAPEUTICS INC ownership

ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 46 filers reported holding ARGOS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$15,000
+150.0%
40,889
+219.4%
0.00%
Q1 2017$6,000
-94.1%
12,800
-37.9%
0.00%
Q4 2016$101,000
+34.7%
20,600
+36.4%
0.00%
Q3 2016$75,00015,1000.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Pharmstandard International S.A. 13,242,279$5,984,00015.97%
Pharmstandard International S.A. 5,120,604$2,314,0006.17%
SANDERS MORRIS HARRIS LLC 290,424$132,0000.02%
WEDBUSH SECURITIES INC 63,500$29,0000.00%
Virtu KCG Holdings LLC 127,073$57,0000.00%
Alyeska Investment Group, L.P. 200,000$90,0000.00%
WASATCH ADVISORS LP 186,900$85,0000.00%
STATE STREET CORP 184,194$82,0000.00%
SG Americas Securities, LLC 17,652$8,0000.00%
MEEDER ASSET MANAGEMENT INC 398$00.00%
View complete list of ARGOS THERAPEUTICS INC shareholders